|
According to your definition, SSNHL is defined as hearing loss that can develop over a period of:
|
|
Less than 24 h
|
21
|
40.4
|
|
48 h
|
8
|
15.4
|
|
72 h
|
15
|
28.8
|
|
7 days
|
8
|
15.4
|
|
Which of the following referrals do you make upon presentation of suspected unilateral SSNHL? Check all that apply.
|
|
Labwork
|
9
|
17.3
|
|
CT
|
8
|
15.4
|
|
MRI
|
9
|
17.3
|
|
Audiologic Evaluation
|
46
|
88.5
|
|
Otolaryngology consultation
|
42
|
80.8
|
|
Neurology consultation
|
2
|
3.8
|
|
Emergency Department
|
10
|
19.2
|
|
When presented with unilateral, acute or sudden-onset hearing loss, do you attempt to differentiate between conductive and sensorineural hearing loss?
|
|
Yes
|
38
|
73.1
|
|
No
|
14
|
26.9
|
|
Do you use tuning fork tests to differentiate between conductive and sensorineural hearing loss?
|
|
Yes
|
33
|
63.5
|
|
No
|
19
|
36.5
|
|
Do you feel comfortable interpreting a formal audiogram to differentiate between a conductive hearing loss and sensorineural hearing loss?
|
|
Yes
|
16
|
30.8
|
|
No
|
36
|
69.2
|
|
As a family physician, which of the following pharmacologic agents do you prescribe as treatment when presented with suspected unilateral SSNHL, prior to confirmation with audiological testing? Check all that apply.
|
|
Corticosteroids
|
39
|
75
|
|
Antivirals
|
6
|
11.5
|
|
Thrombolytics
|
0
|
0
|
|
Vasodilators
|
0
|
0
|
|
Other (e.g. antibiotics)
|
0
|
0
|
|
None of the above
|
1
|
1.9
|
|
I do not prescribe any pharmacologic agents when presented with suspected SSNHL
|
12
|
23.1
|
|
Which of the following topics do you include as part of counselling to patients presenting with unilateral SSNHL? Check all that apply.
|
|
Possible causes
|
28
|
53.8
|
|
Available treatment options and associated risks/benefits
|
26
|
50
|
|
Impact on Quality of Life
|
13
|
25
|
|
Rehabilitation options (e.g. hearing aids)
|
6
|
11.5
|
|
None of the above
|
1
|
1.9
|
|
I do not counsel patients presenting with SSNHL as I am rarely certain of the diagnosis upon initial presentation
|
22
|
42.3
|
